An interventional study of VIP Program in Risk Behavior, sponsored by University of Miami. Completed at 1 site in United States. Open to participants aged 10 Years to 17 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-06-26.
Sponsored by University of Miami · Not applicable, Interventional, and Prevention
The primary purpose of this study is to evaluate the effectiveness and perceived usefulness of the Values in Perspective (VIP) program in reducing and preventing engagement in risky behaviors among youths. The VIP program is a structured, values-based intervention designed to promote self-awareness, ethical decision-making, and long-term goal setting in young people. This study aims to assess how participation in the program influences youths' attitudes, knowledge, and behaviors related to common adolescent risk factors such as substance use, unsafe sexual activity, and delinquency. The goal is to determine whether the VIP program can serve as a scalable and culturally relevant prevention strategy to promote positive youth development and reduce high-risk behaviors in middle and high school-aged youths.
Exclusion criteria
Participants in this group will receive a 26 week course on risk reduction strategies.
Behavioral: VIP Program
This intervention will engage the participants with psychoeducational material once a week. This material will include didactic instruction as well as participant engagement in developmentally appropriate activities.
SRAE Scores - Middle School
Sexual Risk Avoidance Education Program (SRAE) for middle school participants has a total score ranging from 0 to 170 with a higher score indicating higher risk behavior.
Time frame: Up to 26 weeks
SRAE Scores - High School
Sexual Risk Avoidance Education Program (SRAE) for high school participants has a total score ranging from 0 to 190 with a higher score indicating higher risk behavior.
Time frame: Up to 26 weeks
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Jun 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Miami